Teleflex Incorporated (TFX) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
Total Revenue Chart for Teleflex Incorporated
Teleflex Incorporated (TFX) revenue for FY2025 was USD 2.0B, a -34.6% change from FY2024. Teleflex Incorporated's revenue grew from USD 171.8M in 1985 to USD 2.0B in 2025 (1059.9% over 40 years). Earnings per share grew from USD 2.83 in 2000 to USD -20.25 in 2025 (-815.5%). Revenue compound annual growth rate: 5-year CAGR of -4.7%, 10-year CAGR of 1.0%, 20-year CAGR of -1.2%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $5.77B
- Implied Share Price
- $136.29
- Enterprise Value
- $7.86B
- Revenue (TTM)
- $2.25B
- EBITDA
- $403.90M
- Profit Margin
- -45.76%
- Trailing P/E
- —
- Forward P/E
- 11.01
- Price/Book (MRQ)
- 1.82
- Price/Sales (TTM)
- 2.56
- EV/EBITDA
- 30.73
- EV/Revenue
- 3.49
- Dividend Yield
- 1.00%
- Book Value
- $68.55
- Free Cash Flow (FY2025)
- $245.44M
- Free Cash Flow Yield
- 4.25%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.